Real-world safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy for locally advanced esophageal squamous cell carcinoma

Abstract Background Neoadjuvant chemotherapy with docetaxel, cisplatin plus 5-FU (DCF) has become the new standard of care for locally advanced esophageal squamous cell carcinoma (ESCC). In a real-world setting, the efficacy, recurrence, and adverse events (AEs) remain unclear. Methods This retrospe...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Mikako Tamba, Hiroki Osumi, Mariko Ogura, Shota Fukuoka, Akihiko Okamura, Jun Kanamori, Yu Imamura, Koichiro Yoshino, Shohei Udagawa, Takeru Wakatsuki, Eiji Shinozaki, Masayuki Watanabe, Kensei Yamaguchi, Keisho Chin, Akira Ooki
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2025-04-01
Serija:	BMC Cancer
Teme:	Neoadjuvant chemotherapy Esophageal squamous cell carcinoma DCF
Online dostop:	https://doi.org/10.1186/s12885-025-14011-4
Oznake:	Označite Brez oznak, prvi označite!